X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (224) 224
Publication (32) 32
Book / eBook (3) 3
Book Review (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (135) 135
female (98) 98
male (76) 76
index medicus (75) 75
adult (73) 73
rheumatology (72) 72
middle aged (66) 66
article (27) 27
immunology (26) 26
aged (23) 23
rheumatoid-arthritis (23) 23
systemic lupus erythematosus (23) 23
lupus (22) 22
animals (21) 21
disease (20) 20
immunosuppressive agents - therapeutic use (18) 18
erythematosus (17) 17
health aspects (17) 17
lupus erythematosus, systemic - immunology (17) 17
revised criteria (17) 17
classification (16) 16
cyclophosphamide - therapeutic use (16) 16
double-blind method (16) 16
lupus erythematosus, systemic - drug therapy (16) 16
therapy (15) 15
adolescent (14) 14
analysis (14) 14
risk factors (14) 14
abridged index medicus (13) 13
cyclophosphamide (13) 13
research (13) 13
young adult (13) 13
cyclophosphamide - adverse effects (12) 12
drug therapy (12) 12
expression (12) 12
medicine, general & internal (12) 12
research article (12) 12
risk (12) 12
severity of illness index (12) 12
t cells (12) 12
follow-up studies (11) 11
disease-activity (10) 10
immunosuppressive agents - adverse effects (10) 10
lupus erythematosus, systemic - complications (10) 10
medicine (10) 10
prospective studies (10) 10
treatment outcome (10) 10
child (9) 9
granulomatosis with polyangiitis - drug therapy (9) 9
lupus erythematosus, systemic - blood (9) 9
lupus erythematosus, systemic - physiopathology (9) 9
lymphocytes (9) 9
mortality (9) 9
oncology (9) 9
prevalence (9) 9
skin and connective tissue diseases (9) 9
time factors (9) 9
wegener's granulomatosis (9) 9
autoantibodies (8) 8
biology (8) 8
cancer (8) 8
case-control studies (8) 8
cohort studies (8) 8
cyclophosphamide - administration & dosage (8) 8
dna methylation (8) 8
hiv (8) 8
lymphocyte activation (8) 8
methotrexate (8) 8
pharmacokinetics (8) 8
rats (8) 8
vasculitis (8) 8
aids (7) 7
autoimmune diseases (7) 7
biomarkers - blood (7) 7
care and treatment (7) 7
cells, cultured (7) 7
clinical medicine (7) 7
clinical trials (7) 7
dosage and administration (7) 7
drug therapy, combination (7) 7
gene expression (7) 7
genes (7) 7
granulomatosis with polyangiitis - diagnosis (7) 7
immune activation (7) 7
immune system (7) 7
immunosuppressive agents - administration & dosage (7) 7
infectious diseases (7) 7
inflammation (7) 7
intravenous cyclophosphamide (7) 7
lupus erythematosus, systemic - genetics (7) 7
lupus erythematosus, systemic - pathology (7) 7
medical research (7) 7
mice (7) 7
pharmacology & pharmacy (7) 7
respiratory system (7) 7
systemic-lupus-erythematosus (7) 7
women (7) 7
antiretroviral therapy (6) 6
atherosclerosis (6) 6
autoimmunity (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Rheumatology, ISSN 0315-162X, 02/2014, Volume 41, Issue 2, pp. 300 - 309
Journal Article
Journal Article
Current Opinion in Rheumatology, ISSN 1040-8711, 05/2019, Volume 31, Issue 3, pp. 213 - 222
PURPOSE OF REVIEWMedical therapies for the treatment of immune thrombocytopenia (ITP) complicating SLE are increasingly being investigated as alternatives to... 
SYSTEMIC-LUPUS-ERYTHEMATOSUS | thrombocytopenia | immunosuppression | SINGLE-CENTER | RHEUMATOLOGY | lupus | REFRACTORY AUTOIMMUNE THROMBOCYTOPENIA | platelets | LOW-DOSE RITUXIMAB | ANTI-D TREATMENT | CYCLOSPORINE-A | INTRAVENOUS IMMUNOGLOBULIN | TERM-FOLLOW-UP | 2ND LINE THERAPY | splenectomy | MYCOPHENOLATE-MOFETIL
Journal Article
Journal Article
Journal Article
Current Opinion in Rheumatology, ISSN 1040-8711, 05/2018, Volume 30, Issue 3, pp. 229 - 230
Journal Article
BLOOD, ISSN 0006-4971, 10/2007, Volume 110, Issue 8, pp. 2907 - 2915
Individuals with systemic lupus erythematosus (SLE) have a striking increase in premature atherosclerosis of unclear etiology. Accelerated endothelial cell... 
ENDOTHELIAL PROGENITOR CELLS | APOPTOSIS | INTERFERON-ALPHA | SIGNALING PATHWAYS | INHIBITION | DENDRITIC CELLS | HEMATOLOGY | EXPRESSION | ERYTHEMATOSUS | IFN-ALPHA | I INTERFERON
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2017, Volume 76, Issue Suppl 2, p. 150
BackgroundPreliminary safety and efficacy data from the Phase II BEL open-label extension study (LBSL02; NCT00071487) have been reported.ObjectivesHere we... 
Lupus | Stockholders | Prednisone | Systemic lupus erythematosus | Intravenous administration
Journal Article
Current Opinion in Rheumatology, ISSN 1040-8711, 05/2018, Volume 30, Issue 3, pp. 249 - 255
PURPOSE OF REVIEWAntimalarial drugs including chloroquine, its less toxic quinolone-derivative hydroxychloroquine (HCQ), and quinacrine have become... 
blood levels | hydroxychloroquine | antimalarial | retinopathy | spectral domain optical coherence tomography | renal insufficiency | RHEUMATOID-ARTHRITIS | SYSTEMIC-LUPUS-ERYTHEMATOSUS | OPTICAL COHERENCE TOMOGRAPHY | RISK | RHEUMATOLOGY | RETINAL TOXICITY | CESSATION | CHLOROQUINE RETINOPATHY | MULTIFOCAL ELECTRORETINOGRAPHY | RECOMMENDATIONS | LONG-TERM COURSE | Hydroxychloroquine - therapeutic use | Retinal Diseases - prevention & control | Rheumatic Diseases - drug therapy | Humans | Retinal Diseases - chemically induced | Rheumatic Diseases - blood | Hydroxychloroquine - adverse effects | Corneal Diseases - prevention & control | Dose-Response Relationship, Drug | Corneal Diseases - chemically induced | Antirheumatic Agents - adverse effects | Female | Renal Insufficiency - complications | Retrospective Studies | Hydroxychloroquine - blood | Antirheumatic Agents - therapeutic use | Retinal Diseases - diagnosis | Antirheumatic Agents - blood | Drug Administration Schedule | Retinal Diseases - complications | Tomography, Optical Coherence | Risk Factors | Chloroquine - blood | Chloroquine - therapeutic use | Chloroquine - adverse effects | Corneal Diseases - diagnosis | Mass Screening | Rheumatic Diseases - complications | Tamoxifen - adverse effects | Drug Monitoring | Practice guidelines (Medicine) | Hydroxychloroquine | Safety and security measures | Analysis | Index Medicus
Journal Article
Journal of Autoimmunity, ISSN 0896-8411, 2012, Volume 41, pp. 60 - 71
Abstract Women develop lupus more frequently than men and the reason remains incompletely understood. Evidence that men with Klinefelter's Syndrome (XXY)... 
Allergy and Immunology | Lupus | Epigenetics | MicroRNA | Gene expression | Women's health | X chromosome | N-ACETYLGLUCOSAMINE | ACTIVATION | DNA METHYLATION | C-CBL | IMMUNOLOGY | DISEASE-ACTIVITY | ERYTHEMATOSUS PATIENTS | ESTROGEN | O-GLCNAC | EXPRESSION | LYMPHOCYTES | Leukocytes, Mononuclear - metabolism | DNA Methylation - immunology | Proto-Oncogene Proteins c-cbl - metabolism | Humans | Middle Aged | Lupus Erythematosus, Systemic - metabolism | N-Acetylglucosaminyltransferases - genetics | Immunoblotting | Male | Transcriptome - immunology | CD40 Ligand - immunology | CD4-Positive T-Lymphocytes - immunology | CD40 Ligand - metabolism | Genes, X-Linked - immunology | Leukocytes, Mononuclear - immunology | Lupus Erythematosus, Systemic - immunology | Adult | Female | Proto-Oncogene Proteins c-cbl - genetics | Receptors, CXCR3 - metabolism | Leukocytes, Mononuclear - drug effects | Genes, X-Linked - genetics | N-Acetylglucosaminyltransferases - immunology | CD4-Positive T-Lymphocytes - metabolism | Cells, Cultured | MicroRNAs - immunology | Reverse Transcriptase Polymerase Chain Reaction | N-Acetylglucosaminyltransferases - metabolism | Azacitidine - pharmacology | CD40 Ligand - genetics | Lupus Erythematosus, Systemic - genetics | Receptors, CXCR3 - genetics | Receptors, CXCR3 - immunology | Sex Factors | MicroRNAs - genetics | Proto-Oncogene Proteins c-cbl - immunology | Women | Autoimmunity | Analysis | Genes | Genetic research | Genetic aspects | T cells | Methylation | Health aspects | microRNA | women’s health | epigenetics | gene expression
Journal Article
ARTHRITIS & RHEUMATOLOGY, ISSN 2326-5191, 11/2014, Volume 66, Issue 11, pp. 3096 - 3104
Objective. To assess the efficacy and safety of a 24-week course of abatacept in the treatment of active lupus nephritis and to assess the potential of... 
RHEUMATOID-ARTHRITIS | GLOMERULONEPHRITIS | THERAPY | ERYTHEMATOSUS SLE | INTRAVENOUS CYCLOPHOSPHAMIDE | MURINE LUPUS | RANDOMIZED-TRIAL | CLASSIFICATION | COSTIMULATION | RHEUMATOLOGY | MYCOPHENOLATE-MOFETIL
Journal Article